Detail page

Knowledge Web

Person

Karl-Josef Langen (1959-)

Arzt

Name	Karl-Josef Langen
Time	1959- (Date of birth and death)
Place	Immerath (Geburtsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Hochschullehrer
Related	Institut für Neurowissenschaften und Medizin (Jülich)
Further information	Universitätspfofessor und Leiter der Arbeitsgruppe: Nuklearmedizinische Hirntumordiagnostik, Institut für Neurowissenschaften und Medizin Physik der Medizinischen Bildgebung (INM-4)
Source	Vorlage
Record type	Person
GND-Identifier	1088807836
Record ID	1088807836
Involved in show all Assessment of brain tumour perfusion using early-phase 18F-FET PET: comparison with perfusion-weighted MRI Assessment of Brain Tumour Perfusion Using Early-Phase 18F-FET PET: Comparison with Perfusion-Weighted MRI Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial Correction to: Repeated amino acid PET imaging for longitudinal monitoring of brain tumors The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial Correction to : Repeated amino acid PET imaging for longitudinal monitoring of brain tumors GABAA receptor availability relates to emotion-induced BOLD responses in the medial prefrontal cortex : simultaneous fMRI/PET with [11C]flumazenil Hybrid PET/MRI in Cerebral Glioma : Current Status and Perspectives Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma : a lesion-function and resting-state fMRI analysis Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression Repeated amino acid PET imaging for longitudinal monitoring of brain tumors Update nuklearmedizinische Bildgebung von Gehirntumoren und -metastasen Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [11C]ABP688 PET/MR-EEG Post-stroke treatment with argon preserved neurons and attenuated microglia/macrophage activation long-termly in a rat model of transient middle cerebral artery occlusion (tMCAO) Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET : The Forschungszentrum Jülich Experience Use of advanced neuroimaging and artificial intelligence in meningiomas 18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection Imaging of Response to Radiosurgery and Immunotherapy in Brain Metastases: Quo Vadis? 18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma : moving towards a multimodal imaging-guided resection 18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection A Fast Protocol for Multiparametric Characterisation of Diffusion in the Brain and Brain Tumours A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer's Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients Excitatory–inhibitory balance within EEG microstates and resting-state fMRI networks: assessed via simultaneous trimodal PET–MR–EEG imaging Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1(G93A) Transgenic Mice PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement Sex-Related Motor Deficits in the Tau-P301L Mouse Model Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems High uptake of 68Ga-PSMA and 18F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes High uptake of 68Ga-PSMA and 18F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes Investigation of Cerebral O-(2-[18F]Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET A preliminary study on machine learning-based evaluation of static and dynamic FET-PET for the detection of pseudoprogression in patients with IDH-wildtype glioblastoma A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems Bolus infusion scheme for the adjustment of steady state [11C]Flumazenil levels in the grey matter and in the blood plasma for neuroreceptor imaging Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors Investigation of cerebral o-(2-[18f]fluoroethyl)-l-tyrosine uptake in rat epilepsy models mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia Pet/mri radiomics in patients with brain metastases Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Karl-Josef Langen (1959-)

Assessment of brain tumour perfusion using early-phase 18F-FET PET: comparison with perfusion-weighted MRI

Assessment of Brain Tumour Perfusion Using Early-Phase 18F-FET PET: Comparison with Perfusion-Weighted MRI

Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial

Correction to: Repeated amino acid PET imaging for longitudinal monitoring of brain tumors

The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis

Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial

Correction to : Repeated amino acid PET imaging for longitudinal monitoring of brain tumors

GABAA receptor availability relates to emotion-induced BOLD responses in the medial prefrontal cortex : simultaneous fMRI/PET with [11C]flumazenil

Hybrid PET/MRI in Cerebral Glioma : Current Status and Perspectives

Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival

The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma : a lesion-function and resting-state fMRI analysis

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression

Repeated amino acid PET imaging for longitudinal monitoring of brain tumors

Update nuklearmedizinische Bildgebung von Gehirntumoren und -metastasen

Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas

mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [11C]ABP688 PET/MR-EEG

Post-stroke treatment with argon preserved neurons and attenuated microglia/macrophage activation long-termly in a rat model of transient middle cerebral artery occlusion (tMCAO)

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression

Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET : The Forschungszentrum Jülich Experience

Use of advanced neuroimaging and artificial intelligence in meningiomas

18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection

Imaging of Response to Radiosurgery and Immunotherapy in Brain Metastases: Quo Vadis?

18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma : moving towards a multimodal imaging-guided resection

18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection

A Fast Protocol for Multiparametric Characterisation of Diffusion in the Brain and Brain Tumours

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model

Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET

Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis

Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes

Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes

Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer's Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients

Excitatory–inhibitory balance within EEG microstates and resting-state fMRI networks: assessed via simultaneous trimodal PET–MR–EEG imaging

Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1(G93A) Transgenic Mice

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement

Sex-Related Motor Deficits in the Tau-P301L Mouse Model

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems

High uptake of 68Ga-PSMA and 18F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes

High uptake of 68Ga-PSMA and 18F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes

Investigation of Cerebral O-(2-[18F]Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

A preliminary study on machine learning-based evaluation of static and dynamic FET-PET for the detection of pseudoprogression in patients with IDH-wildtype glioblastoma

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma

An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems

Bolus infusion scheme for the adjustment of steady state [11C]Flumazenil levels in the grey matter and in the blood plasma for neuroreceptor imaging

Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors

Investigation of cerebral o-(2-[18f]fluoroethyl)-l-tyrosine uptake in rat epilepsy models

mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia

Pet/mri radiomics in patients with brain metastases

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI

Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study

Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study